Molbio Diagnostics IPO
Molbio Diagnostics Limited (MOLBIO) · mainboard IPO on NSE and BSE · 100% Book Building. Listed on 17 August 2026.
Issue details
Listing day
Back-tested estimate (from a model that had only seen earlier years' IPOs): listing gain +17.6% (likely range +16% to +38%), day's high +27.7%, chance of a gain 92%. Actual: +21.4% at the open, +31.9% at the high.
Subscription status
| Category | Shares offered | Shares bid for | Subscribed | |
|---|---|---|---|---|
| QIB (institutions) | 23,25,145 | 43,33,82,148 | 186x | |
| NII (HNI) total | 17,43,860 | 8,68,40,604 | 49.8x | |
| Big NII (above ₹10 lakh) | 11,62,574 | 5,90,76,594 | 50.8x | |
| Small NII (₹2-10 lakh) | 5,81,286 | 2,77,64,010 | 47.8x | |
| Retail | 40,69,005 | 5,27,19,318 | 13.0x | |
| Employees | 20,519 | 2,72,466 | 13.3x | |
| Total | 81,58,529 | 57,32,14,536 | 70.3x |
Bids on NSE and BSE together, as published by NSE, as of 12 Aug 2026, 07:00 PM. Shares offered exclude the anchor portion. 8% of all shares bid for were at the cut-off price.
Past IPOs with similar demand
Earlier mainboard IPOs whose QIB, NII and retail subscription and size were closest to Molbio Diagnostics's, and how they listed.
| IPO | QIB | NII | Retail | Total | Size | Listing gain | Day high |
|---|---|---|---|---|---|---|---|
| SBFC FinanceAug 2023 | 193x | 49.1x | 11.0x | 70.2x | ₹1,082 Cr | +43.9% | +67.5% |
| Atlanta ElectricalsSep 2025 | 195x | 54.2x | 10.4x | 70.6x | ₹697 Cr | +13.7% | +14.7% |
| Bansal Wire IndustriesJul 2024 | 146x | 51.5x | 13.6x | 59.6x | ₹785 Cr | +39.1% | +45.3% |
| Seshaasai TechnologiesSep 2025 | 190x | 49.9x | 9.17x | 68.1x | ₹825 Cr | +2.1% | +3.4% |
| Happy ForgingDec 2023 | 220x | 62.2x | 15.1x | 82.0x | ₹1,006 Cr | +17.6% | +27.9% |
| IKIO LightingJun 2023 | 164x | 63.4x | 13.9x | 66.3x | ₹615 Cr | +37.7% | +50.0% |
Lead managers and their listing record
| Book running lead manager | Mainboard IPOs since 2019 | Avg listing gain | Listed at a premium |
|---|---|---|---|
| Kotak Mahindra Capital Company | 83 | +20.8% | 76% |
| IIFL Capital Services | 94 | +19.3% | 71% |
| Jefferies India | 26 | +19.5% | 81% |
| Motilal Oswal Investment Advisors | 47 | +15.0% | 72% |
Offer documents (NSE)
Frequently asked
What is the Molbio Diagnostics IPO price band and lot size? ₹768–807 per share, with a lot of 18 shares, so the smallest retail bid is ₹14,526.
How many times has it been subscribed? 70.3x overall: QIB 186x, NII 49.8x, retail 13.0x, employees 13.3x.
How did it list? It opened at ₹980, +21.4% against the issue price of ₹807, and closed its first day +29.1%.
